Protalix Biotherapeutics Inc (PLX)
R&D Expenses
$4.35M
Quarterly · Period ending: · USD
PLX R&D Expenses
Latest reported$4.35Mperiod ending
Latest reported$4.35Mperiod ending
PLX Quarterly R&D Expenses ($0.00 → $4.35M)
Quarterly R&D Expenses
High-resolution chart · PNG
PLX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |